ARCHIVES

Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

NIH Spent $181.3 Million on PR Last Year; House Probe Prompts Analysis of Spending

July 12, 2013

Q & A: NCI’s Doroshow Says Phase I Program Will Stress Correlative Studies for Small Biotech Firms

April 6, 2012

Aging Committee Hears Prospects For Immunotherapy

July 27, 1979

NCI Grants Awarded To Develop Special Populations Networks. AACR Honors Feinstein, Khayat.

April 7, 2000

In Brief: Lenhard Elected President Of ACS; House Science Committee Approves CRADA Bill

November 17, 1995

NCI Extramural Program: Advisors Approve Concepts For Diagnostic Imaging Trials Group

March 21, 1997